Psoricaid Research

In vivo studies show that Psoricaid was able to reduce inflammation in mice. In one study, the synovial membrane of the ankle joint in a mouse model was infiltrated with inflammatory cells. At a dose of 20 mglkg Psoricaid, the formation of the synovial membrane was inhibited and the undamaged cartilage could be seen. In another study, Psoricaid was able to inhibit the carrageenan-induced swelling of rat hind paws in a pituitary-adrenal-independent manner.

D. Metcalf, DC from MN, has a 52-year-old male patient who has rheumatoid arthritis (RA). His knuckles are always painful and difficult to move. It has been difficult to treat because he also has large granular lymphocyte (LGL) leukemia. Treatment of RA involves suppressing the immune system; however, with LGL leukemia, you need to increase immunity. He tried methotrexate (good for cancer and RA) with Celebrex but with no use. In Feb 2006, he switched to Angiostop, Psoricaid, Asparagus Extract, Myosteo, and Reishi Spore Extract. His pain was completely alleviated and he regained total movement of his hands. Although his platelets are still low, his energy has increased.

E. Schlabach, DC from OH, has a 24-year-old female patient with psoriasis (topical dermatitis type) on the scalp, neck, back and abdominal area. She's had the condition for 5-6 years with breakouts usually in the Spring and Fall. She tried various topical cortisones, licorice root and even colonies to no avail. After only 3 weeks on Psoricaid, her condition has improved by 95%.